U.S. Markets close in 3 hrs.

Myrexis, Inc. (MYRX)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.072+0.009 (+14.105%)
As of 10:12AM EDT. Market open.
People also watch

Myrexis, Inc.

630 Fifth Avenue
Suite 2260
New York, NY 10020
United States

IndustryDrugs - Generic
Full Time Employees1

Key Executives

Mr. Jonathan M. Couchman CFAChairman, CEO, Pres, CFO and Principal Accounting Officer1N/A47
Amounts are as of December 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

Corporate Governance

Myrexis, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.